Search

everythinglearnresearchcommunity

for

Search:↓

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Thyroid hormones are important for skin health and changes in them can affect conditions like hair loss and eczema.

Different types of fibroblasts play various roles in kidney repair and aging, and may affect chronic kidney disease outcomes.

A pregnant woman with Cushing Syndrome got worse and sadly passed away.

PCOS is managed with medication, lifestyle changes, and a healthy diet.

Dermatopathology has made significant progress but many skin diseases remain incurable, requiring ongoing research.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Thyroid hormones affect skin texture, hair and nail growth, and can cause skin diseases related to thyroid problems.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Women in Raichur slums need better health awareness and medical help.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

Many patients with Alopecia Areata in Korea experience anxiety, depression, and reduced quality of life, which are often unrelated to the severity of hair loss.

Nanoemulgels could effectively treat skin diseases and may replace or complement current therapies.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

Sex and sex hormones can affect brain inflammation in Parkinson's disease, with male mice being more affected and female mice showing a protective effect.

Severe and early hair loss may indicate a higher risk of heart disease.

COVID-19 vaccination may lower vitamin D levels and cause hair loss.

Individualized treatments may help manage Dercum's disease symptoms.